ABVC BioPharma, Inc. (NASDAQ:ABVC – Get Free Report) was the target of a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 360,300 shares, a drop of 42.6% from the December 31st total of 628,000 shares. Currently, 3.2% of the company’s shares are sold short. Based on an average daily volume of 266,100 shares, the short-interest ratio is presently 1.4 days.
ABVC BioPharma Stock Performance
ABVC BioPharma stock opened at $0.52 on Friday. The company has a 50 day moving average price of $0.54 and a 200-day moving average price of $0.62. ABVC BioPharma has a fifty-two week low of $0.41 and a fifty-two week high of $1.73. The company has a market capitalization of $6.75 million, a PE ratio of -0.60 and a beta of 0.70.
ABVC BioPharma Company Profile
Featured Stories
- Five stocks we like better than ABVC BioPharma
- Following Congress Stock Trades
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to Short Nasdaq: An Easy-to-Follow Guide
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Pros And Cons Of Monthly Dividend Stocks
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for ABVC BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABVC BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.